TL;DR: Hypermobile Ehlers-Danlos syndrome (hEDS) takes an average of 19 to 22 years to diagnose. It is more common than most physicians realize, affects multiple body systems at once, and is routinely mistaken for fibromyalgia, anxiety, or IBS. Proper care requires treating all three dimensions: structural, neuroplastic, and somatic. Fragmented specialist care rarely works.

What you need to know:

• hEDS affects an estimated 1 in 500 people, with a strong female predominance [2]

• The average diagnostic delay is 19 to 22 years [1][2]

• More than half of hypermobile patients in specialized clinics carry both an hEDS and fibromyalgia diagnosis [4]

• Central sensitization, a rewired pain-processing system, drives much of the widespread pain [5][6]

• Comprehensive care must address the structural body, the sensitized nervous system, and the emotional cost of years of being dismissed

She sat down in my office and started with an apology.

“I know I probably sound crazy. I’ve seen twelve doctors.”

She was 41. Her pain started at 19. A rheumatologist told her it was fibromyalgia. A GI doctor said IBS. A pelvic floor PT said she had a tight pelvic floor. A psychiatrist put her on an SSRI for what he called “health anxiety.”

Nobody had ever checked if she was hypermobile.

I ran the Beighton score. She scored 8 out of 9. Her elbows hyperextended. Her thumbs touched her forearms. She could plant her palms flat on the floor without bending her knees.

Twenty-two years of being told nothing was wrong. And nobody had ever asked her to bend her thumb.

That detail stays with me more than it probably should. It’s such a simple test.

In my clinical practice, I use the Beighton score in combination with the Brighton Criteria to diagnose patients on the hypermobility spectrum. The Beighton gives a quick, standardized measure of joint mobility across nine maneuvers. The Brighton Criteria go further: they incorporate the Beighton score alongside symptoms like chronic arthralgia, a history of joint dislocations, soft tissue involvement, skin changes, and autonomic features [9]. Used together, they produce a more complete clinical picture. The Brighton Criteria have been validated with a sensitivity and specificity of 93% each [10]. The Beighton alone can miss patients who are hypermobile but score just below the cutoff, or patients whose hypermobility has decreased with age but whose symptoms persist. The Brighton framework captures those patients. That matters, because missing them means another decade of wrong diagnoses.

Why Does hEDS Take 19+ Years to Diagnose?

In June 2026, a research team at the University of Edinburgh published one of the largest diagnostic-delay studies ever done on hypermobile Ehlers-Danlos syndrome (hEDS) [1].

The average time between symptom onset and diagnosis? 19 to 21 years. [1]

Not months. Not a few years. Two decades.

A woman starts experiencing joint pain, gut issues, dizziness on standing, and unexplained fatigue at 18. She receives a proper hEDS diagnosis at 39. In between, she has been told she is anxious, deconditioned, hormonal, drug-seeking, or dramatic.

By the time she walks into my office, she is not just in pain. She is in grief. She has grieved careers she had to leave. Pregnancies that broke her body in ways nobody prepared her for. Friendships that faded because she cancelled too often. A version of herself she can barely remember.

This is the population I work with every day at Body and Mind Pain Center in Sherman Oaks. Hypermobile women who have been failed by a medical system that was never trained to see them.

Key Point: The diagnostic delay is not random. hEDS presents as ten different things across ten different specialists, and no single clinician is trained to connect them into one picture.

What Is hEDS? A Plain Explanation

Hypermobile Ehlers-Danlos syndrome is a heritable connective tissue disorder. The connective tissue throughout the body, tendons, ligaments, fascia, skin, blood vessels, gut wall, is structurally different. More elastic. More fragile. Less able to hold joints, organs, and the nervous system in a stable resting state.

That single physiological reality creates a cascade of downstream symptoms:

• Joints that sublux and dislocate under normal loads

• Chronic musculoskeletal pain that shifts location

• Dysautonomia and postural orthostatic tachycardia syndrome (POTS)

• Gastrointestinal dysmotility and food sensitivities

• Pelvic floor dysfunction

• Mast cell activation

• Anxiety, panic, and sleep disturbance

hEDS is not rare. Current prevalence estimates put it as high as 1 in 500 to 1 in 600 people, with strong female predominance [2]. It gets systematically overlooked because it presents as ten different things across ten different specialists, and nobody connects the dots.

A cardiologist sees the POTS. A GI doc sees the bloating. A rheumatologist sees the pain. A therapist sees the anxiety. Each treats their piece. Nobody steps back and asks the obvious question: what if all of this is one condition?

Key Point: hEDS is a whole-body connective tissue condition. Treating individual symptoms in isolation without understanding the underlying physiology is why so many patients stay stuck.

The Fibromyalgia Overlap: What the Research Shows

A systematic review published in 2023 found that fibromyalgia and hypermobile connective tissue disorders co-occur at strikingly high rates [3]. A 2023 EDS Clinic study of 733 patients found that 56.5% carried both an hEDS/HSD and fibromyalgia diagnosis simultaneously [4].

More than half of hypermobile patients in specialized EDS clinics also carry a fibromyalgia diagnosis [4]. Most have been diagnosed with only one, usually fibromyalgia, and treated as if the hypermobility was incidental.

The hypermobility is causal, not incidental.

When connective tissue is looser, the nervous system does more work to hold the body together. The proprioceptive system runs harder. The autonomic nervous system stays on higher alert. Over years, that sustained vigilance rewires the pain-processing pathways in the brain and spinal cord. This is central sensitization, and it is the mechanism behind fibromyalgia [5].

A hypermobile 22-year-old whose pain started small becomes a 35-year-old with widespread, unexplained pain that no imaging can account for. She gets the fibromyalgia label. She is told to exercise, sleep better, and manage stress.

Nobody tells her that her fibromyalgia is downstream of her hypermobility, and that treating one without addressing the other will not work.

Key Point: Fibromyalgia and hEDS are frequently misread as separate diagnoses when they are often the same process unfolding across time. Central sensitization is the shared mechanism, and it has to be treated directly.

Pelvic Pain and the Hypermobile Body

In July 2026, a research team published one of the clearest studies to date linking hypermobility signs directly to specific pelvic pain conditions, including vulvodynia, endometriosis pain patterns, interstitial cystitis, and pelvic floor dysfunction.

Hypermobile women are not imagining that their pelvic pain got worse after childbirth. Or that intercourse hurts in ways their friends don’t describe. Or that their bladder feels wrong all the time.

Their pelvic floor is holding up connective tissue that does not support itself the way it should. Their pelvic organs sit differently. Their autonomic nervous system, already running hot, is hyper-reactive to any pelvic input.

Standard pelvic floor PT often makes these patients worse. Aggressive internal release work on a hypermobile pelvis can destabilize it further and increase pain. Kegels prescribed to a pelvic floor that is already gripping in guarded protection tighten what needs to soften.

Proper pelvic care for a hypermobile patient looks completely different. It has to.

Key Point: Pelvic pain in hypermobile women requires clinicians who understand connective tissue physiology. Standard protocols applied without that understanding frequently increase symptoms.

How a Sensitized Nervous System Drives Chronic Pain

Every hypermobile patient reading this deserves to understand one thing.

Being hypermobile means your nervous system is running at a higher baseline sensitivity. That is physiology, not weakness.

When joints move through wider ranges, the brain has to work harder to know where the body is in space. Interoceptive signalling, the internal sensing of heart rate, digestion, breath, temperature, is amplified. The sympathetic nervous system stays partially engaged because the body reads instability as threat.

Over time, this creates what pain neuroscience calls a sensitized central nervous system [6]. The pain volume gets turned up. Signals that should not register as painful, gentle pressure, temperature changes, gut motility, are experienced as pain. Emotional stress hits the body harder because there is less neurological buffer.

This is why so many of my hypermobile patients are also burnt-out healthcare workers, nurses, physicians, therapists, first responders. Their physiology was already running hot. Then they entered a profession that demands constant nervous system output. By 35, they are barely functional. And nobody has connected the dots between the hypermobility they have had since childhood and the burnout that broke them at work.

Key Point: Central sensitization in hEDS is not a psychological phenomenon. It is a measurable neurological adaptation to years of structural instability and threat signaling. It requires targeted nervous system treatment, not reassurance.

Why December 2026 Matters for the hEDS Community

In December 2026, a global consortium is releasing updated international diagnostic criteria for hypermobile EDS [8].

For patients who have been ignored, dismissed, and misdiagnosed for decades, this is not a routine update. The new criteria are expected to broaden recognition, refine the overlap with related hypermobility spectrum disorders, and create clearer diagnostic pathways for clinicians who currently have no framework at all.

If you suspect you have hEDS, here is what to do between now and December:

1. Get your Beighton score documented in writing by a clinician who knows what they are doing.

2. Build a symptom timeline. Include joint symptoms, GI issues, POTS-type symptoms, pelvic pain, migraines, and mental health history. This becomes your diagnostic map.

3. Ask about genetics if there are red flags for other EDS subtypes. hEDS is currently diagnosed clinically, but ruling out vascular or classical EDS matters.

4. Find clinicians who understand connective tissue disorders. Ones who see this population regularly, not occasionally.

The December criteria will help. They will not fix a system that has spent 20 years missing you. That part still requires finding the right care.

Key Point: Updated criteria are a necessary first step toward shorter diagnostic timelines. They matter most when clinicians are trained to use them, and patients know to ask for them.

What Proper Care for hEDS Actually Looks Like

Comprehensive care for a hypermobile patient with central sensitization and multi-system involvement has three pillars. All three have to be present. Missing any one of them leaves the patient stuck.

1. Structural

• Musculoskeletal ultrasound to assess joint stability and soft tissue integrity

• Targeted strength work that stabilizes without overloading

• Regenerative interventions (PRP, prolotherapy) where structural laxity is driving pain

• Movement retraining that respects the connective tissue reality of the body

2. Neuroplastic

• Pain reprocessing therapy to address the sensitized pain-processing circuits [7]

• Polyvagal-based interventions to shift the autonomic nervous system out of chronic threat

• Sleep, nutrition, and circadian rhythm work as nervous system inputs

• Education about pain neuroscience so the patient understands what is happening in their own body

3. Somatic

• Emotional Awareness and Expression Therapy for the layers of grief and trauma that come with 20 years of being dismissed

• Internal Family Systems-informed work for the protective responses that have kept the patient functional but exhausted

• Trauma-informed body work that respects hypermobility and does not push a nervous system that is already overwhelmed

💡 The single most important shift: proper care treats the whole person as one interconnected system, not as a list of specialty complaints to be routed to different clinicians who never talk to each other.

Key Point: Structural, neuroplastic, and somatic care are not optional add-ons. They are the three legs of a stool. Remove one and the whole thing falls.

If You Have Been Waiting

If your pain has been labeled anxiety and you know your body well enough to know that’s not the whole story.

If you have been told you are deconditioned, and you remember clearly when your body could do more than this.

If you have tried what they recommended, and nothing has held.

You are not broken. You have been underdiagnosed.

You have likely been living with a physiological reality that the medical system was never trained to see. You have been asked to explain your own body to clinicians who did not have the framework to understand what you were describing.

That changes when you find care that starts by believing you.

Body and Mind Pain Center

At Body and Mind Pain Center in Sherman Oaks, we work with hypermobile patients, women with complex pelvic pain, healthcare workers in burnout, and people who have been through the medical system and come out unheard.

Our approach integrates interventional pain medicine, regenerative orthobiologics, musculoskeletal ultrasound, pain reprocessing therapy, polyvagal-based somatic work, and trauma-informed care. Coordinated, under one roof, focused on treating you as one system.

If you have been waiting 19 years, or 10, or 2, you should not have to wait longer.

To schedule an evaluation, visit Body and Mind Pain Center in Sherman Oaks or reach us through bodymindpain.com.

You have already done the hardest part. You kept looking.

Frequently Asked Questions

What is hypermobile Ehlers-Danlos syndrome (hEDS)?

hEDS is a heritable connective tissue disorder characterized by joint hypermobility, chronic pain, and multi-system involvement. It affects an estimated 1 in 500 people and is most common in women.

Why does hEDS take so long to diagnose?

hEDS presents across multiple body systems simultaneously. Each specialist typically treats their piece, and no single clinician connects them. Research shows the average diagnostic delay is 19 to 22 years [1][2].

Is fibromyalgia the same as hEDS?

They are distinct diagnoses, but they frequently co-occur. A 2023 study found that 56.5% of hEDS patients also carry a fibromyalgia diagnosis [4]. Fibromyalgia in hypermobile patients is often driven by central sensitization that originates from structural instability.

What is central sensitization and why does it matter in hEDS?

Central sensitization is a state in which the nervous system becomes increasingly reactive to input. In hEDS, years of joint instability and autonomic overactivation can rewire pain-processing circuits so that ordinary sensations register as painful. Research shows central sensitization occurs in up to 86.5% of hEDS patients [5].

What does proper treatment for hEDS look like?

Effective care addresses three pillars simultaneously: structural stability (ultrasound-guided procedures, targeted exercise), neuroplastic retraining (pain reprocessing therapy, polyvagal work), and somatic healing (trauma-informed care, grief processing). Treating one pillar without the others produces incomplete results.

Can pelvic pain be caused by hEDS?

Yes. Hypermobile connective tissue affects pelvic organ support, pelvic floor muscle tone, and autonomic reactivity to pelvic input. Standard pelvic PT protocols can worsen symptoms in hypermobile patients if they do not account for connective tissue physiology.

What is happening with hEDS diagnostic criteria in December 2026?

A global consortium is releasing updated international diagnostic criteria for hEDS [8]. The update is expected to broaden recognition and create clearer pathways for clinicians who currently lack a diagnostic framework for this population.

How do I know if I might have hEDS?

Key indicators include joint hypermobility (assessed using both the Beighton score and the Brighton Criteria for greater diagnostic sensitivity and specificity [9][10]), chronic shifting musculoskeletal pain, dysautonomia symptoms (dizziness on standing, heart pounding), GI issues, pelvic pain, and a long history of unexplained multi-system symptoms. Seek evaluation from a clinician experienced with connective tissue disorders who uses both tools together, not the Beighton score alone.

Key Takeaways

• hEDS affects an estimated 1 in 500 people and has an average diagnostic delay of 19 to 22 years [1][2]

• More than half of hypermobile patients in specialized clinics carry both an hEDS and fibromyalgia diagnosis, because central sensitization links the two [3][4][5]

• The nervous system of a hypermobile person is running at higher baseline sensitivity. This is physiology, not psychology

• Standard treatments (pelvic PT, exercise prescriptions, CBT alone) frequently fail because they address symptoms without understanding the underlying connective tissue reality

• Comprehensive care requires structural, neuroplastic, and somatic treatment working together

• Updated diagnostic criteria arriving in December 2026 may shorten future delays, but finding knowledgeable clinicians remains the most urgent need for patients today

• You are not broken. You have been underdiagnosed. And that is a solvable problem

---

About the Author:
Dr. Zev Nevo is a double board-certified physiatrist, chronic pain survivor, and founder of the Body & Mind Pain Center. He helps people with persistent pain rebuild capacity and confidence using an evidence-based, trauma-informed mind-body rehabilitation approach.

Listen: Mind Your Body Podcast

Learn & Join: Mind-Body Rehabilitation Community

Visit the Clinic: Body & Mind Pain Center

Medical Disclaimer:
The information in this article is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this article. New or changing pain symptoms should always be properly evaluated by a medical professional.

---

References

1. Barron A, Sherwood R, Henderson E, et al. The lived experience of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders in the United Kingdom: findings from a national cross-sectional survey. Disabil Rehabil. 2026. doi:10.1080/09638288.2026.2646723

2. Hamonet C, et al. Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs. PubMed. 2025. PMC12386360

3. Alsiri N, Palmer S. The concomitant diagnosis of fibromyalgia and connective tissue disorders: a systematic review. Semin Arthritis Rheum. 2023. doi:10.1016/j.semarthrit.2022.152074

4. Eccles JA, et al. High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities. Am J Med Genet C Semin Med Genet. 2023. PMC10166812

5. Desai H, et al. Evidence for central sensitization as classified by the central sensitization inventory in patients with pain and hypermobility. Pain Pract. 2025;25:e13411. doi:10.1111/papr.13411

6. Di Stefano G, et al. Linking central sensitization to multisystemic manifestations in hypermobile Ehlers-Danlos syndrome. Front Pain Res. 2026. doi:10.3389/fpain.2026.1799439

7. Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):13-23. doi:10.1001/jamapsychiatry.2021.2669

8. The Ehlers-Danlos Society. Road to 2026: Updated International Diagnostic Criteria for EDS and HSD. eds.clinic/articles/2026-eds-criteria-update

9. Grahame R, Bird HA, Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol. 2000;27(7):1777–1779. PMID: 10914867

10. Mena-Garcia L, et al. Hypermobility spectrum disorders: A review. PMC / NIH. 2023. PMC10457547 — Brighton Criteria validated at 93% sensitivity and specificity for joint hypermobility syndrome.